Ms Kelly Dunn Will, OTR | |
548 E Laguna Dr, Tempe, AZ 85282-5336 | |
(480) 620-4226 | |
Not Available |
Full Name | Ms Kelly Dunn Will |
---|---|
Gender | Female |
Speciality | Occupational Therapist - Pediatrics |
Location | 548 E Laguna Dr, Tempe, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043359300 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225XP0200X | Occupational Therapist - Pediatrics | 2627 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Kelly Dunn Will, OTR 548 E Laguna Dr, Tempe, AZ 85282-5336 Ph: () - | Ms Kelly Dunn Will, OTR 548 E Laguna Dr, Tempe, AZ 85282-5336 Ph: (480) 620-4226 |
News Archive
"Chinese authorities will step up the release of water from the Three Gorges Dam in a bid to tackle a drought in southern China which has put pressure on drinking water, crops, shipping lanes and electricity production in what is traditionally China's most water-abundant region," the Financial Times reports.
As COVID-19 continues to spread, bottlenecks in supplies and laboratory personnel have led to long waiting times for results in some areas.
Vascular Solutions, Inc. today announced that it has acquired the assets related to the EXPRO Elite™ and MICRO Elite™ snare products from Radius Medical Technologies, Inc. and its subsidiary, Radius Medical, LLC. Vascular Solutions has been selling the EXPRO Elite™ and MICRO Elite™ snares in the U.S. under a distribution relationship with Radius since 2008, while in international markets Radius has been selling the products through a network of independent distributors.
Angelman syndrome is a genetic disease with no cure. Children grow up with severe intellectual disabilities and a range of other problems, arguably the worst of which are epileptic seizures. Now scientists at the UNC School of Medicine have found evidence that genetic therapy may prevent the enhanced seizure susceptibility.
Amgen today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care compared to BSC alone. The analysis used massively parallel, next-generation sequencing technology to investigate whether mutations in nine genes known to be mutated in colorectal cancer, including the previously unanalyzed exon 3 mutation of the KRAS gene, are predictive of response to Vectibix in metastatic colorectal cancer.
› Verified 4 days ago
Ms. Susan L Fetter, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 215 W Lodge Dr, Tempe, AZ 85283 Phone: 480-730-4103 Fax: 480-897-0014 | |
Angela Holly, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1400 E Southern Ave, 310, Tempe, AZ 85282 Phone: 602-567-9881 | |
Mrs. Rachel Ann Jackson Belanger, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3311 S Holbrook Ln, Tempe, AZ 85282 Phone: 480-518-4602 | |
Cheryl Ray, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3205 S Rural Rd, Tempe, AZ 85282 Phone: 480-730-7100 | |
Lilian Quizon Manaloto, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1640 E Verlea Dr, Tempe, AZ 85282 Phone: 602-300-8955 | |
Megan Flesner, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1761 E Warner Rd Ste B1, Tempe, AZ 85284 Phone: 480-882-4934 |